Suppr超能文献

氨甲环酸对纤溶酶将单链组织型纤溶酶原激活剂转化为其二链形式的抑制作用:组织型纤溶酶原激活剂上存在与纤溶酶赖氨酸结合位点结合的位点。

Inhibition by tranexamic acid of the conversion of single-chain tissue plasminogen activator to its two chain form by plasmin: the presence on tissue plasminogen activator of a site to bind with lysine binding sites of plasmin.

作者信息

Takada A, Takada Y

机构信息

Department of Physiology, Hamamatsu University, School of Medicine, Shizuoka, Japan.

出版信息

Thromb Res. 1989 Sep 15;55(6):717-25. doi: 10.1016/0049-3848(89)90302-2.

Abstract

The addition of tranexamic acid inhibited the conversion of single chain tissue plasminogen activator (sct-PA) to its two chain form (tct-PA) by plasmin. Increase in the concentrations of tranexamic acid resulted in more inhibition of the conversion, with 50% inhibition being obtained at 0.251 mM of the concentration of tranexamic acid. The addition of the fragments of plasminogen such as kringle 1 to 3 (K1-3), and K4 resulted in the facilitation of the conversion of sct-PA to tct-PA by plasmin. The addition of tranexamic acid to the mixture of sct-PA and K4 inhibited the rate of the conversion of sct-PA by plasmin. These results suggest that binding of lysine binding sites of plasmin or plasminogen with sct-PA enhanced its conversion to tct-PA by plasmin, and that there is a site on a t-PA molecule to bind to plasminogen or plasmin.

摘要

氨甲环酸的加入抑制了纤溶酶将单链组织型纤溶酶原激活剂(sct-PA)转化为其二链形式(tct-PA)。氨甲环酸浓度的增加导致对这种转化的抑制作用增强,当氨甲环酸浓度为0.251 mM时可达到50%的抑制率。加入纤溶酶原片段如kringle 1至3(K1-3)和K4可促进纤溶酶将sct-PA转化为tct-PA。向sct-PA与K4的混合物中加入氨甲环酸可抑制纤溶酶对sct-PA的转化速率。这些结果表明,纤溶酶或纤溶酶原的赖氨酸结合位点与sct-PA的结合增强了纤溶酶将其转化为tct-PA的能力,并且在t-PA分子上存在一个可与纤溶酶原或纤溶酶结合的位点。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验